Qiping YIN - 香港中文大學學術研究文庫

印綺平教授 (已離職)

中大研究成果

1/3

CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects (2013)

Effects of Grapefruit Juice and SLCO1B1 388A > G Polymorphism on the Pharmacokinetics of Pitavastatin (2013)

Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects (2012)

Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects (2012)

Electrocardiographic effects and plasma concentrations of flecainide and propafenone in healthy Chinese subjects (2011)

Pharmacogenetics of Labetalol are Influenced by CYP2C19 rather Than CYP2D6 (2010)

Polymorphisms in Drug Transporters Rather than Drug Metabolizing Enzymes Influence the Pharmacokinetics but not Adverse Effects with Clonazepam (2010)

Interaction of ABCG2 Transporter Polymorphism 421C>A and the Effect of Grapefruit Juice on the Pharmacokinetics of Pitavastatin (2008)

Interaction of Pitavastatin with Grapefruit Juice in Subjects with Different Efflux Transporter BCRP ABCG2 421C>A Genotypes (2008)

Does the cytochrome P450 2D6 polymorphism influence simvastatin plasma concentrations in Chinese subjects? (2007)

Effect of CYP2D6 Genotype on Simvastatin Pharmacokinetics in Chinese Subjects (2007)

Effects of the cytochrome P450 2D6*10 polymorphism on the pharmacokinetics of simvastatin and simvastatin acid in Chinese Subjects (2007)

Comparison of pharmacokinetic variability of metformin in German Caucasian and Chinese subjects (2006)

CYP3A5 but not CYP2D6 Polymorphism Affects Dextropropoxyphene Disposition in Human Subjects (2006)

Cytochrome P-450 2D6 genotype has a major effect on lovastatin pharmacokinetics in Chinese subjects (2006)

Genetic polymorphism of OCT2 gene and haplotype profile in the Chinese population (2006)

High-Throughput in Vitro Cocktail Method for Screening the Inhibitory Effects of CYP ISOZYMES (2006)

Identification of Single Nucleotide Polymorphisms of Human OCT2 in Chinese Population (2006)

No Association between CYP3A5 Genotype and Blood Pressure in Healthy Chinese Subjects (2006)

Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients (2006)

Population pharmacokinetics of cyclosporine in Chinese cardiac transplant recipients (2006)

Variability in renal clearance of substrates for renal transporters in Chinese subjects (2006)

A five-drug cocktail for phenotyping of CYP isozymes in human subjects (2005)

A Probe-Drug Cocktail Approach for Assessing Herb Drug Interaction (2005)

A probe-drug cocktail approach for assessing herb-drug interaction (2005)

Clinical bioequivalence study on two allopurinol formulations (2005)

Clinical bioequivalence study on two amoxicillin formulations (2005)

Clinical Bioequivalence Study on Two Ampicillin Formulations (2005)

Clinical bioequivalence study on two paracetamol/dextropropoxyphene formulations (2005)

Clinical Bioequivalence Study on Two Simvastatin Formulations (2005)

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects (2005)

Effect of CYP2D6*10 allele on the pharmacokinetics of loratadine in Chinese subjects (2005)

Effects of combined CYP2C9 and 2C19 polymorphism on the pharmacokinetics of glibenclamide in Chinese subjects. (2005)

Pharmacokinetic Data as Evidence of Quality and Effect of Chinese Medicinal Product (2005)

Pharmacokinetics and modeling of quercetin and metabolites (2005)

Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients (2005)

Phenotype-genotype relationship and clinical effects of venlafaxine in Chinese patients (2005)

Population pharmacokinetics of cyclosporine in Chinese cardiac transplant patients (2005)

Simultaneous determination of paracetamol and dextropropoxyphene in human plasma by liquid chromatography/tandem mass spectrometry: application to clinical bioequivalence studies (2005)

The Application of a Biopharmaceutic/Pharmacokinetic Approach for Quality Control of TCM Products (2005)

The Application of a Biopharmaceutic/Pharmacokinetic Approach for Quality Control of Traditional Chinese Medicine Products (2005)

Validation of an LC-MS-MS Method for the Simultaneous Determination of IMD-1041 and IMD-0354 in Human Plasma (2005)

A Pharmacokinetic-Genomic Approach for Prediction of Herb-Drug Interaction: Experience with Ginkgo Biloba (2004)

A Pharmacokinetic Model for Describing the Effect of Ginkgo-biloba on Omeprazole Disposition (2004)

Budesonide/Formoterol: a Valuable Treatment Option for Asthma and Chronic Obstructive Pulmonary Disease (2004)

Clinical Bioequivalence Study on Two Glibenclamide Formulations (2004)

Clinical Bioequivalence Study on Two Griseofulvin Formulations (2004)

Clinical Bioequivalence Study on Two Metformin Formulations (2004)

分享連結

Our policy towards the use of cookies